Utilization of Sacubitril/Valsartan in Real-World Settings

被引：0
|
作者：
Efe Eworuke
Talia J. Menzin
Emily C. Welch
Joy Kolonoski
Ting-Ying Huang
机构：
[1] U.S. Food and Drug Administration,Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research
[2] Harvard Medical School and Harvard Pilgrim Health Care Institute,Department of Population Medicine
来源：
American Journal of Cardiovascular Drugs | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：619 / 623
页数：4
相关论文
共 50 条
  • [41] Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
    Polito, Maria Vincenza
    Silverio, Angelo
    Rispoli, Antonella
    Vitulano, Gennaro
    D'Auria, Federica
    De Angelis, Elena
    Loria, Francesco
    Gigantino, Alberto
    Bonadies, Domenico
    Citro, Rodolfo
    Carrizzo, Albino
    Galasso, Gennaro
    Iaccarino, Guido
    Vecchione, Carmine
    Ciccarelli, Michele
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [42] Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction
    Mapelli, Massimo
    Salvioni, Elisabetta
    de Martino, Fabiana
    Mattavelli, Irene
    Bonomi, Alice
    Sassi, Valentina
    Gugliandolo, Paola
    Vignati, Carlo
    Magini, Alessandra
    Rovai, Sara
    Paolillo, Stefania
    Agostoni, Piergiuseppe
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (11) : 882 - 888
  • [43] Effect of sacubitril/valsartan therapy on risk stratification biomarkers in a real-world heart failure population
    Barrett, M. J.
    Hammond, M.
    Zhou, S.
    Hanlon, R. O.
    Campbell, P.
    Mcdonald, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 585 - 586
  • [44] Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real-world study
    Chen, Wenwen
    Liu, Yanlin
    Li, Yuanmin
    Dang, Heqin
    ESC HEART FAILURE, 2021, 8 (05): : 3783 - 3790
  • [45] PHARMACOUTILIZATION AND ADHERENCE TO SACUBITRIL/VALSARTAN IN REAL-WORLD: THE REAL.IT STUDY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    Iacoviello, M.
    Di Gesaro, G.
    Sarullo, F.
    Miani, D.
    Driussi, M.
    Correale, M.
    Bilato, C.
    Passantino, A.
    Carluccio, E.
    Villani, A.
    Esposti, L. Degli
    D'Agostino, C.
    Peruzzi, E.
    Poli, S.
    Di Lenarda, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [46] Sacubitril/Valsartan in real world heart failure proctice in Asia
    Chu, P. H.
    Hsia, F. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 412 - 412
  • [47] Sacubitril-valsartan prescription during heart failure hospitalization: real-world initial experience.
    Morillas Climent, H.
    Galcera Jornet, E.
    Alania Torres, E.
    Seller Moya, J.
    Vicedo Lopez, A.
    Rodriguez Pichardo, Y.
    Larumbe Rodriguez, A.
    Valle Munoz, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 309 - 309
  • [48] Is Sacubitril/Valsartan Under-Prescribed in The United States? A Real-World Insight from The Explorys Registry
    Khayata, Mohamed
    Al Al-Kindi, Sadeer
    Njoroge, Linda
    Oliveira, Guilherme H.
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S13 - S13
  • [49] A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system
    Wang, Yiwen
    Liu, Xuna
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [50] Effects of sacubitril/valsartan on real-world patients with heart failure due to non-ischemic cardiomyopathy
    Hsu, C-Y
    Lin, Y-C
    Huang, C-Y
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 407 - 408
12345